8-K: Perdoceo Education Corporation Finalizes Acquisition of University of St. Augustine for Health Sciences

Sentiment:

Merger Announcement


Perdoceo Education Corporation has completed its acquisition of the University of St. Augustine for Health Sciences for $138 million, net of cash acquired, and reaffirmed its full-year adjusted operating income outlook.

Summary

  • Perdoceo Education Corporation has successfully acquired the University of St. Augustine for Health Sciences (USAHS) for approximately $138 million, net of cash acquired.
  • The acquisition was completed on December 2, 2024, and USAHS is now a wholly-owned subsidiary of Perdoceo.
  • USAHS is a leading university offering graduate health sciences degrees, with campuses and online programs.
  • For the nine months ended September 30, 2024, USAHS had unaudited revenues of approximately $114 million and adjusted operating income of approximately $25 million.
  • Perdoceo expects the acquisition to be accretive to its adjusted operating income starting in 2025, with further growth expected in 2026.
  • Perdoceo has reaffirmed its full-year adjusted operating income outlook of $188 million to $191 million for 2024.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the successful acquisition and reaffirmed financial outlook. The acquisition is expected to be accretive, which is a positive signal for investors. However, there are some risks associated with the integration, which temper the overall sentiment slightly.

Positives

  • The acquisition of USAHS is expected to immediately boost Perdoceo's adjusted operating income starting in 2025.
  • USAHS is a well-established university with a strong reputation in health sciences education.
  • The acquisition provides Perdoceo with a new avenue for growth in the health sciences sector.
  • Perdoceo has reaffirmed its full-year adjusted operating income outlook, indicating confidence in its financial performance.

Negatives

  • The purchase price of $138 million is subject to post-closing adjustments and escrow arrangements, which could impact the final cost.
  • There are risks associated with integrating the acquired business, including potential disruptions and unexpected liabilities.

Risks

  • Perdoceo may not achieve the anticipated benefits of the transaction.
  • The acquired business may not perform as expected.
  • Perdoceo may assume unexpected risks, liabilities, and obligations of the acquired business.
  • Significant transaction costs could impact profitability.
  • Disruptions from the transaction could harm the parties' businesses.
  • There is a risk of not retaining key personnel.
  • Adverse reactions or changes to business relationships could result from the acquisition.

Future Outlook

Perdoceo expects the acquisition to be accretive to its adjusted operating income starting in 2025, with further growth expected in 2026. The company also reaffirmed its full-year adjusted operating income outlook for 2024.

Management Comments

  • Perdoceo remains on track to achieve its full year adjusted operating income outlook of $188 million to $191 million.
  • Perdoceo expects the transaction to be accretive to the Company's adjusted operating income immediately beginning in 2025 and the transaction to provide further growth in adjusted operating income in 2026.

Industry Context

The acquisition of USAHS aligns with the trend of consolidation in the higher education sector, particularly in specialized fields like health sciences. This move allows Perdoceo to expand its offerings and potentially capture a larger share of the market for graduate health science programs.

Comparison to Industry Standards

  • The acquisition of USAHS is similar to other strategic acquisitions in the education sector, where companies seek to expand their program offerings and geographic reach.
  • For example, other education companies have acquired specialized institutions to diversify their portfolios and enhance their market position.
  • The reported revenue and operating income of USAHS for the nine months ended September 30, 2024, are within the expected range for a university of its size and specialization.

Stakeholder Impact

  • Shareholders are likely to view the acquisition positively due to the expected accretion to earnings.
  • Employees of both Perdoceo and USAHS may experience changes as the two organizations integrate.
  • Students of USAHS will become part of the Perdoceo network of institutions.
  • Suppliers and other business partners of USAHS will now be dealing with Perdoceo.

Next Steps

  • Perdoceo will integrate USAHS into its operations.
  • The company will file the required financial statements and pro forma information in an amendment to this report within 71 days.
  • Perdoceo will continue to monitor the performance of USAHS and its impact on the company's overall financial results.

Key Dates

DateDescription
July 15, 2024Date of the Agreement and Plan of Merger.
December 2, 2024Closing date of the acquisition of University of St. Augustine for Health Sciences.

Keywords

acquisition, Perdoceo Education Corporation, University of St. Augustine for Health Sciences, USAHS, health sciences, adjusted operating income, postsecondary education, merger

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.